AU2022362077A1 - Treatment of kidney disease - Google Patents

Treatment of kidney disease Download PDF

Info

Publication number
AU2022362077A1
AU2022362077A1 AU2022362077A AU2022362077A AU2022362077A1 AU 2022362077 A1 AU2022362077 A1 AU 2022362077A1 AU 2022362077 A AU2022362077 A AU 2022362077A AU 2022362077 A AU2022362077 A AU 2022362077A AU 2022362077 A1 AU2022362077 A1 AU 2022362077A1
Authority
AU
Australia
Prior art keywords
patient
egfr
approximately
kidney
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022362077A
Other languages
English (en)
Inventor
Timothy A. Bertram
Deepak Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2022362077A1 publication Critical patent/AU2022362077A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dermatology (AREA)
AU2022362077A 2021-10-14 2022-10-14 Treatment of kidney disease Pending AU2022362077A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163255885P 2021-10-14 2021-10-14
US63/255,885 2021-10-14
US202263307801P 2022-02-08 2022-02-08
US63/307,801 2022-02-08
US202263321204P 2022-03-18 2022-03-18
US63/321,204 2022-03-18
PCT/US2022/078153 WO2023064925A1 (en) 2021-10-14 2022-10-14 Treatment of kidney disease

Publications (1)

Publication Number Publication Date
AU2022362077A1 true AU2022362077A1 (en) 2024-05-02

Family

ID=85988933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022362077A Pending AU2022362077A1 (en) 2021-10-14 2022-10-14 Treatment of kidney disease

Country Status (8)

Country Link
US (1) US20250009803A1 (https=)
EP (1) EP4415729A4 (https=)
JP (1) JP2024536479A (https=)
KR (1) KR20240110801A (https=)
AU (1) AU2022362077A1 (https=)
CA (1) CA3233866A1 (https=)
MX (1) MX2024004355A (https=)
WO (1) WO2023064925A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106530A1 (en) * 2023-11-13 2025-05-22 Butler Emily Characteristics of enriched heterogeneous renal cell populations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020266168A1 (en) * 2019-05-02 2021-12-02 ProKidney IPCo, LLC Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies

Also Published As

Publication number Publication date
WO2023064925A1 (en) 2023-04-20
US20250009803A1 (en) 2025-01-09
JP2024536479A (ja) 2024-10-04
CA3233866A1 (en) 2023-04-20
KR20240110801A (ko) 2024-07-16
EP4415729A4 (en) 2025-08-27
WO2023064925A8 (en) 2024-04-11
EP4415729A1 (en) 2024-08-21
MX2024004355A (es) 2024-06-21

Similar Documents

Publication Publication Date Title
US12350292B2 (en) Bioactive renal cells for the treatment of chronic kidney disease
WO2014075589A1 (zh) 一种间充质干细胞注射液及其制备方法和在制备治疗糖尿病药物中的应用
US20120276067A1 (en) Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
US20250268944A1 (en) Stromal stem cell therapeutics and methods of use
US20070172447A1 (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
US20250009803A1 (en) Treatment of kidney disease
EP3490570A1 (en) Bioactive renal cells for the treatment of chronic kidney disease
CN118354777A (zh) 肾脏疾病的治疗
HK40113884A (zh) 肾脏疾病的治疗
Seeley et al. Suspected COVID-19 immunization-induced probable catastrophic antiphospholipid syndrome
Schmid et al. New strategies for managing anemia of chronic kidney disease
CN114350607B (zh) 骨髓来源的成熟b细胞及其在制备治疗心肌梗死的药物中的应用
Gariani et al. Impact of Islet Transplantation on Type 1 Diabetes-Related Complication: A Systematic Review
TWI780431B (zh) 新穎性醫藥組合物及其於修復肝臟損傷、治療肝臟損傷相關疾病與提升肝臟功能之用途
Parlatır et al. Effect of Intravenous Adipose Tissue-Derived Mesenchymal Stem Cell Administration on Glycemic Index in a Cat with Diabetes Mellitus
EP4146235A1 (en) Methods for treating coronavirus disease
Simu et al. ISCHEMIC STROKE IN SYSTEMIC LUPUS ERYTHEMATOSUS-A CASE REPORT.
Hillyer Morbidity and mortality in adults with idiopathic thrombocytopenic purpura: JFA Portielje, RGI Westendorp, HC Kluin-Nelemans, et al. Blood 97: 2549–2554, 2001
Kröpfl E-mail: christina. spengler@ hest. ethz. ch
Martini et al. Therapeutic applications of stem cells obtained from peripheral blood in tendons, ligaments and skin injuries
Kutsogiannis Donor Organ Management: Literature Review
Avades Renal Effects of X-ray Contrast Media in Different Experimental Models
Fridell et al. Mini-Orals: Clinical Pancreas and Islet Transplantation
Lundgren Evaluation of strategies to predict and improve early graft survival in clinical islet transpalntation
Sampaio et al. Detection and Monitoring of Cytomegalovirus Infection, Human Herpesvirus-6 and Human Herpesvirus-7 in Liver Transplantation: Clinical Correlation Laboratory.: Abstract# P-365